Local Application of the TLR-9 Agonist Dims0150 in Moderately Severe Ulcerative Colitis Patients

Trial Profile

Local Application of the TLR-9 Agonist Dims0150 in Moderately Severe Ulcerative Colitis Patients

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Oct 2013

At a glance

  • Drugs Cobitolimod (Primary)
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Oct 2013 Results reporting changes from baseline in Disease Activity Index subscale scores presented at the 21st United European Gastroenterology Week.
    • 05 Jun 2013 New trial record
    • 18 May 2013 Results of a biomarker analysis presented at the Digestive Disease Week 2013.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top